|NOTA-FAPI/CAS:2374782-03-1 is a fibroblast activation protein (FAP) inhibitor. NOTA-FAPI can be used as a probe for FAP-targeted tumour imaging. NOTA-FAPI has good tumour detection efficacy and excellent imaging quality.
|HYNIC-PSMA is a ligand for molecular imaging of tumors. Hynic-psma consists of two components: HYNIC (6-hydrazinonicotinamide) and PSMA (Prostate-Specific Membrane Antigen). HYNIC is a compound used to attach radioactive isotopes to targeted molecules, such as 188Re-HYNIC-PSMA. PSMA is a membrane antigen that is specifically expressed on the surface of prostate cancer cells. HYNIC-PSMA can be used in prostate cancer research.
|NOTA PSMA/Cas: 1575386-67-2, macrocyclic compound PSMA, is a ligand with unique properties. PSMA is a non-essential, low-abundance membrane protein with glutamate carboxypeptidase B activity. PSMA is expressed in prostate cancer but is not expressed or has low expression in normal prostate tissue. NOTA-PSMA is a targeted imaging agent based on PSMA (prostate-specific membrane antigen) that can be used for the diagnosis and treatment of prostate cancer.
|PSMA-ligand-1/CAS:1610413-97-2 is a molecule that specifically binds to prostate-specific membrane antigen (PSMA). This molecule is used in diagnostic imaging techniques, such as positron emission tomography (PET) scans, to detect and locate prostate cancer lesions. Additionally, PSMA-ligand-1 conjugated to a therapeutic compound can be used in targeted therapy to deliver treatment directly to PSMA-expressing cancer cells. The development and use of PSMA-ligand-1 hold promise for improving the early detection and treatment of prostate cancer.
|PSMA-BCH/CAS: 1703768-73-3 also known as NOTA-PSMA, is a PSMA- NOTA-conjugated precursor. 68Ga-PSMA-BCH can be used for prostate cancer imaging. Al18F-PSMA-BCH can be used for prostate cancer imaging as a novel 18F PET radiotracer. 64Cu-PSMA-BCH is a new radiotracer for delayed PET imaging of prostate cancer. 64Cu-PSMA-BCH was PSMA specific and showed high stability in vivo with lower uptake in liver than 64Cu-PSMA-617. Biodistribution in mice and PCa patients showed similar profile compared with other PSMA ligands and it was safe with moderate effective dosimetry.
|Folate-NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid)/CAS: 1778691-88-5 is a molecule that is used in the field of molecular imaging, particularly in positron emission tomography (PET) imaging. The attachment of folate, a form of vitamin B9, to NOTA creates a specific molecular complex that can target cancer cells that overexpress folate receptors.
|The macrocyclic ligand compound NOTA-NEB is a molecular probe. It has a large circular structure, can form stable complexes with metal ions, and has good stability and biocompatibility. NOTA-NEB has good affinity and stability in macrocyclic ligand compounds, and can form stable complexes with metal ions, thus possessing good coordination properties. It has a low electron density and good reducibility.
|NO2A-Azide/CAS：2125661-92-7 refers to a compound derived from the NO2A chelating ligand, which is often used in the creation of radiopharmaceuticals for molecular imaging applications. NO2A-Azide represents a potential tool for the development of molecular imaging probes and radiopharmaceuticals, offering opportunities for targeted imaging and diagnostic applications in the field of nuclear medicine and medical imaging.
|NO2A-Butyne-bis (t-Butyl ester)
|NO2A-Butyne-bis (t-Butyl ester) refers to a chemical compound used in the field of bioconjugation and radiopharmaceutical development, particularly in the context of molecular imaging for nuclear medicine applications.NO2A-Butyne-bis (t-Butyl ester) represents a potential tool for molecular imaging and targeted radiopharmaceutical development, contributing to the advancement of nuclear medicine and medical imaging for diagnostic and research purposes.
|NO2A(tBu) stands for Nitrito-N,N-diacetic acid t-butyl ester. It is a chemical compound that belongs to the family of chelating ligands. In the context of nuclear medicine and molecular imaging, NO2A(tBu) may be used as a bifunctional chelator. NO2A(tBu) represents a potential tool for the development of targeted radiopharmaceuticals and molecular imaging probes, contributing to advancements in nuclear medicine for diagnostic and research purposes.